A Phase II Clinical Study to Evaluate the Efficacy and Safety of KX-826 Tincture in the Treatment of Adult Male Androgenetic Alopecia (AGA) Patients in China
Latest Information Update: 23 Sep 2023
At a glance
- Drugs Pyrilutamide (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors Suzhou Kintor Pharmaceuticals
Most Recent Events
- 28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, data from this study was presented at CSD 2023
- 28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, this study will be presented at EADV 2023.
- 27 Aug 2022 According to a Kintor Pharmaceutical Limited media release, the leading principal investigators, Professor Jianzhong Zhang of Peking University People's Hospital, presented the positive results of the trial at the 6th Annual Meeting of Chinese Hair Research Society sponsored by the Chinese Society of Dermatology.